Temporal trends in major cardiovascular events following first-time myocardial infarction in the reperfusion era – a Danish nationwide cohort study from 2000 to 2017
- 29 August 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Quality of Care and Clinical Outcomes
- Vol. 9 (3) , 268-280
Abstract
We investigated temporal trends in major cardiovascular events following first-time myocardial infarction (MI) and trends in revascularization and pharmacotherapy from 2000 to 2017. Using nationwide registries, we identified 120 833 Danish patients with a first-time MI between 2000 and 2017. We investigated 30-day and 1-year mortality and the 1-year risk of first-time admission for heart failure (HF) and recurrent MI. Patients were younger with a higher prevalence of hypertension and diabetes in 2015–2017 compared with 2000–2002. The patients were predominantly male (65.6%), and the median age declined by 3 years through the periods. Percutaneous coronary interventions within 7 days after first-time MI increased significantly (2000: 11.4% vs. 2017: 68.6%; Ptrend < 0.001). Cardiovascular medication after first-time MI changed significantly in the same period. Absolute risks and adjusted rates of outcomes were significantly lower in 2015–2017 compared with 2000–2002: 30-day mortality: 6.5% vs. 14.1% [hazard ratio (HR) 0.52, 95% confidence interval (CI): 0.48–0.55); 1-year mortality 10.7% vs. 21.8% (HR 0.52, 95% CI: 0.50–0.55); recurrent MI: 4.0% vs. 7.8% (HR 0.56, 95% CI: 0.51–0.62); and first-time admission for HF: 2.9% vs. 3.7% (HR 0.82, 95% CI: 0.73–0.92). The rates of 30-day/1-year mortality and recurrent MI showed significantly decreasing trends (Ptrend < 0.001). The rates of first-time admission for HF were borderline significant (Ptrend = 0.045). From 2000 to 2017, we observed a decreasing risk of recurrent MI, first-time admission for HF, and all-cause mortality in patients with a first-time MI. In the same period, we observed a high rate of guideline-recommended pharmacological treatment after first-time MI as well as increasing rate of early revascularization in Denmark. The results from the current study portrait the risk of all-cause mortality, recurrent MI, and first-time admission for HF in a real-life setting with a very high utilization of early revascularization and guideline-recommended pharmacological therapy. We observed a temporal trend of improved survival, reduced risk of recurrent MI, as well as reduced risk of first-time admission for HF after first-time MI from 2000 through 2017. We observed an increase in the overall use of revascularization, as well as early revascularization and use of guideline-recommended pharmacotherapy. Our study reveals important results from real-life, nationwide data, showing a reduced risk of cardiovascular outcomes after first-time MI during the past 20 years. Current guidelines are based on results from clinical trials. Our real-life results add additionally important knowledge on patients’ prognosis after first-time MI and underline the importance of treating MI according to guideline recommendations.Keywords
Funding Information
- Novo Nordisk Foundation
- Augustinus Foundation
- Kaj Hansen Foundation
- Health Insurance Denmark
- Copenhagen University
- Novo
This publication has 32 references indexed in Scilit:
- The Danish Civil Registration System as a tool in epidemiologyEuropean Journal of Epidemiology, 2014
- The EXAMINATION Trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction)JACC: Cardiovascular Interventions, 2014
- The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of PatientsBMC Medical Research Methodology, 2011
- Predictors and Prognostic Impact of Recurrent Myocardial Infarction in Patients with Left Ventricular Dysfunction, Heart Failure, or Both Following a First Myocardial InfarctionEuropean Journal of Heart Failure, 2011
- World Health Organization definition of myocardial infarction: 2008-09 revisionInternational Journal of Epidemiology, 2010
- Long-Term Trends in the Incidence of Heart Failure After Myocardial InfarctionCirculation, 2008
- Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary EventsHeart, 2007
- EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of populationEuropean Heart Journal, 2006
- Stent Thrombosis Is Associated With an Impaired Response to Antiplatelet TherapyJACC, 2005
- A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial InfarctionNew England Journal of Medicine, 2003